The Cambridge based clinical analytics company Qureight have partnered with Greenlight Guru for their QMS (Quality Management Software). This move will enable Qureight to take their ground breaking cloud based platform through ISO13485 accreditation towards a formal CE mark award.
Qureight was founded in 2018 with a vision to transform routine real-world clinical data into structured information suitable for scientific research and the development of AI tools. The company works with highly specialised data sets from complex diseases including lung fibrosis, complex cancers and covid-19. By partnering with Biopharma, they aim to transform the process of drug development from early clinical trials through to drug reimbursement.
Qureight are developing an improved and streamlined version of its platform harnessing the ability of AI and advanced processing tools to gain new insights into these complex diseases. The partnership with Greenlight Guru will create a strong foundation to bring the Qureight platform to the market in a rapid and safe way.
Qureight CEO Dr. Muhunthan Thillai said “Greenlight Guru has world leading expertise in QMS for medical software. By partnering with them we are ensuring that the Qureight platform has the strongest possible base for which to achieve regulatory compliance as we launch our series of AI based tools in complex diseases. Qureight has entered into some very exciting territories with Biopharma clients in the UK, Europe and the USA. As we move to consolidate these relationships and develop world leading AI solutions to structure complex data, we know that working with Greenlight Guru will place us in a great position for the next stage of our growth.”
Greenlight Guru CEO David DeRam said: "We're excited to help Dr. Thillai and the Qureight team bring their technology to market. We're optimistic that their AI-based technology will be able to transform the landscape of clinical data, and we're looking forward to equipping them with the perfect quality management system to achieve their goals."
Qureight is a Cambridge based company which uses cloud-based technology to assist in the structuring of image and paired clinical metadata in complex diseases. By structuring data in this way, they allow for the development of AI based tools to better understand diseases including lung fibrosis, complex cancers and covid-19. Clients using the Qureight platform include the drug companies Takeda, Galapagos and Roche.
Visit www.qureight.com for more information.
About Greenlight Guru:
Greenlight Guru is the only quality management software platform designed specifically for medical device companies. The platform helps companies bring safer products to market faster, simplifies FDA and ISO regulatory compliance, and provides a single source of truth by connecting the management of all quality processes like CAPAs, risk, audits, and more. Greenlight Guru's platform is used by thousands of users across the globe to push beyond baseline compliance and achieve True Quality for their medical devices.
Visit www.greenlight.guru for more information.